Risk of developing checkpoint immune pneumonitis and its effect on overall survival in non-small cell lung cancer patients previously treated with radiotherapy

Barrón-Barrón, FelicianoSánchez, Roberto P.Arroyo-Hernández, MarisolBlanco, CarolinaZatarain-Barrón, Zyanya LuciaCatalán, RodrigoRamos-Ramírez, MaritzaCardona-Mendoza, Andrés FelipeFlores-Estrada, DianaArrieta, Oscar2020-11-122020-11-122234-943Xhttps://hdl.handle.net/20.500.12495/5058application/pdfengAttribution 4.0 InternationalRisk of developing checkpoint immune pneumonitis and its effect on overall survival in non-small cell lung cancer patients previously treated with radiotherapyArtículo de revistaCheckpoint immune therapyPneumonitisRadiotherapyNSCLCLung cancerImmune related adverse effectshttps://doi.org/10.3389/fonc.2020.570233instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coRisk of developing checkpoint immune pneumonitis and its effect on overall survival in non-small cell lung cancer patients previously treated with radiotherapyAcceso abiertohttps://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto2020-09-29